← Back to Search

Electronic Cigarette for Tobacco Use

N/A
Waitlist Available
Led By Nicholas Felicione, PhD
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how appealing ZYN, a nicotine pouch, is to people who use cigarettes, smokeless tobacco, and other nicotine products. ZYN offers a tobacco-free way to consume nicotine and delivers it quickly without significant adverse effects.

Eligible Conditions
  • Tobacco Use
  • Tobacco Smoking
  • Smokeless Tobacco Cessation
  • Smoking/Cigarette Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in nicotine boost
Change in sensory response
Secondary study objectives
Change is stress markers

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Order 2 - Electronic Cigarettes and Oral Nicotine productExperimental Treatment2 Interventions
Participants will use each prodcut for up to 30 minutes but will also be permitted to stop use before the end of the 30-minute ad lib use period
Group II: Order 1 - Oral Nicotine product - ZYN and Electronic CigarettesExperimental Treatment2 Interventions
Participants will use each product for up to a 30 minute interval But will also be permitted to stop use before the end of the 30-minute ad lib use period

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
410 Previous Clinical Trials
32,433 Total Patients Enrolled
Nicholas Felicione, PhDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center
Maciej Goniewicz, PhDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center
1 Previous Clinical Trials
216 Total Patients Enrolled

Media Library

Electronic Cigarette Clinical Trial Eligibility Overview. Trial Name: NCT05030194 — N/A
Tobacco Use Research Study Groups: Order 1 - Oral Nicotine product - ZYN and Electronic Cigarettes, Order 2 - Electronic Cigarettes and Oral Nicotine product
Tobacco Use Clinical Trial 2023: Electronic Cigarette Highlights & Side Effects. Trial Name: NCT05030194 — N/A
Electronic Cigarette 2023 Treatment Timeline for Medical Study. Trial Name: NCT05030194 — N/A
Tobacco Use Patient Testimony for trial: Trial Name: NCT05030194 — N/A
~4 spots leftby Nov 2025